Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784)
03/2010
03/31/2010CN101683326A Super concentrated natural allicin tablets with quick-acting antibiosis, anti-inflammation and antivirus and preparation method thereof
03/31/2010CN101683323A Colonic targeted micropill containing vancomycin and preparation method thereof
03/31/2010CN101683315A Preparation method of composite hyaluronic acid-sulfadiazine silver gel
03/31/2010CN101683074A Pharmaceutical composition for disinfecting livestock and poultry environments and aquatic water bodies and preparation method thereof
03/31/2010CN100596279C 'Fu Kang Shu' cream for treating gynecological inflammation and preparation method thereof
03/30/2010US7687637 5-phenylthiazole derivatives and use as Pi3 kinase inhibitors
03/30/2010US7687505 Use of modified pyrimidine compounds to promote stem cell migration and proliferation
03/30/2010US7687490 2-thioethenyl substituted carbapenem derivatives
03/30/2010US7687483 Phosphorus compounds used for improving permeability of drugs such as anticarcinogenic agents to biological barriers; drug delivery
03/30/2010US7687480 Phosphonate compounds
03/30/2010US7687478 for treatment of influenza
03/30/2010US7687074 Prevent adhesion of pathogens; mixture containing fatty acid, or glycerides thereof
03/30/2010CA2583727C New process for the preparation of vinyl-pyrrolidinone cephalosporine derivatives
03/30/2010CA2577525C Inhibitors of hepatitis c virus rna-dependent rna polymerase, and compositions and treatments using the same
03/30/2010CA2467611C Azithromycin dosage forms with reduced side effects
03/30/2010CA2457444C 1h-imidazole derivatives having cb1 agonistic, cb1 partial agonistic or cb1- antagonistic activity
03/30/2010CA2442245C 4,5-dihydro-1h-pyrazole derivatives having potent cb1-antagonistic activity
03/30/2010CA2438651C Mucoadhesive, disintegratable medicinal preparation for active substance administration in veterinary and human medicine
03/30/2010CA2433069C Latent human tuberculosis model, diagnostic antigens, and methods of use
03/30/2010CA2428184C Thiazolylphenylcarbamoylmethyl amide derivative
03/30/2010CA2412205C Medicinal product package for eradication therapy
03/30/2010CA2386850C Hexahydrofuro[2,3-b]furan-3-yl-n-{3-[(1,3-benzodioxol-5-ylsulfonyl)(isobutyl)amino]-1-benzyl-2-hydroxypropyl} carbamate as retroviral protease inhibitor
03/30/2010CA2372633C Staphylococcus aureus antigen-containing whole cell vaccine
03/30/2010CA2364705C Optically pure camptothecin analogues
03/30/2010CA2362277C Spontaneously dispersible n-benzoyl staurosporine compositions
03/30/2010CA2355860C Dosage forms comprising porous particles
03/30/2010CA2229479C Method of promoting angiogenesis
03/30/2010CA2155004C Stable bactericidal/permeability-increasing protein products and pharmaceutical compositions containing the same
03/25/2010WO2010033986A2 Dna cytosine deaminase inhibitors
03/25/2010WO2010033863A2 Vaccine compositions of m2e, ha0 and bm2 multiple antigenic peptides
03/25/2010WO2010033444A1 Crystalline forms of a 2-thiazolyl- 4-quinolinyl-oxy derivative, a potent hcv inhibitor
03/25/2010WO2010033292A2 Method for medical treatment utilizing l-glutathione
03/25/2010WO2010033275A2 Orally administerable vaccine for yersinia pestis
03/25/2010WO2010033227A1 Polymer conjugates of thymosin alpha 1 peptides
03/25/2010WO2010033226A1 Oligomer-protease inhibitor conjugates
03/25/2010WO2010033221A1 Polymer conjugates of protegrin peptides
03/25/2010WO2010033205A1 Polymer conjugates of v681-like peptides
03/25/2010WO2010033198A2 Analogs of indole-3-carbinol and their use as agents against infection
03/25/2010WO2010033043A1 Dendrimeric compounds comprising amino acids, hyperbranched core compound, process for preparation of dendrimeric compounds comprising amino acids and hyperbranched core compound, and use thereof
03/25/2010WO2010033031A1 Multifunctional linker protein containing an antibody against hemagglutinin, a conserved influenza antigen and an immunostimulating carrier binding domain
03/25/2010WO2010032974A2 Improved production method for adefovir dipivoxil
03/25/2010WO2010032816A1 Novel lysophosphatidylserine receptor
03/25/2010WO2010032195A1 Imidazopyridines and imidazopyrimidines as hiv-i reverse transcriptase inhibitors
03/25/2010WO2010032043A2 Formulations
03/25/2010WO2010032041A2 Formulations
03/25/2010WO2010031876A1 Carboxyethylated cyclodextrin polysulfates useful as medicaments
03/25/2010WO2010031829A1 Synergistic combinations of a macrocyclic inhibitor of hcv and a nucleoside
03/25/2010WO2010031801A2 Composition and methods for modulating toll-like receptor activity
03/25/2010WO2010031750A1 Organic compounds for applications in bacterial infections treatment
03/25/2010WO2010031113A1 Viral polypeptides and methods
03/25/2010WO2010006315A3 Alpha-galactosyl ceramide analogs and their use as immunotherapies, adjuvants, and intiviral, antibacterial, and anticancer agents
03/25/2010WO2010005637A3 Electrostatically charged multi-acting nasal application, product, and method
03/25/2010WO2009155489A3 Compositions and methods for treating influenza
03/25/2010WO2009151496A3 Induction of proliferation, effector molecule expression, and cytolytic capacity of hiv-specific cd8+ t cells
03/25/2010WO2009149397A3 Respiratory syncytial virus renders dendritic cells tolerogenic
03/25/2010WO2009149288A3 Extracts of cranberry and methods of using thereof
03/25/2010WO2009148287A3 Novel α-iso-cubebene compound extracted from schisandra chinensis and composition containing the compound as active ingredient for preventing and treating inflammatory diseases
03/25/2010WO2009128867A3 Recombinant biologically contained filovirus
03/25/2010WO2009115252A3 Substituted pyrazolamides and the use thereof
03/25/2010WO2009073620A9 Ido inhibitors
03/25/2010US20100077497 Ip-10 antibodies and their uses
03/25/2010US20100076089 Antimicrobial gel formulations
03/25/2010US20100076076 Novel palladium complexes inhibit n-myristoyltransferase activity in vitro and cancer growth in vivo
03/25/2010US20100076066 Novel IDO Inhibitors and Methods of Use Thereof
03/25/2010US20100076057 TARGET DNA INTERFERENCE WITH crRNA
03/25/2010US20100076046 Antiviral Indoles
03/25/2010US20100076000 Sulfoximine-substituted pyrimidines as cdk- and/or vegf inhibitors, their production and use as pharmaceutical agents
03/25/2010US20100075993 Small molecule inhibitors against west nile virus replication
03/25/2010US20100075988 Tetrahydroquinazoline compounds and their use in preparing medicaments for treating and preventing virosis
03/25/2010US20100075945 Gram-positive carbapenem antibacterials and processes for their preparation
03/25/2010US20100075929 9-aminoacyl tetracycline compounds and methods of use thereof
03/25/2010US20100075917 Thionucleosides and pharmaceutical applications
03/25/2010US20100075913 Pharmaceutical anti-infective composition for inhalation
03/25/2010US20100075901 Novel use of hiv nc protein
03/25/2010US20100075378 Moraxella catarrhalis basb115 polypeptides
03/25/2010US20100074952 Tasted masked veterinary solid compositions
03/25/2010US20100074922 Pneumococcal polysaccharide conjugate vaccine
03/25/2010US20100074920 Peptide vaccine for influenza virus
03/25/2010US20100074919 Circovirus sequences associated with piglet weight loss disease (PWD)
03/25/2010US20100074918 Vaccine
03/25/2010US20100074906 Antibodies Specific for Varicella Zoster Virus
03/25/2010US20100074900 Prostaglandin e2 dual variable domain immunoglobulins and uses thereof
03/25/2010US20100074894 Pharmaceutical composition containing antibodies directed against the herv-w envelope
03/25/2010US20100074892 Monoclonal Antibodies That Neutralize Anthrax Protective Antigen (PA) Toxin
03/25/2010US20100074889 4'-allene-substituted nucleoside derivatives
03/25/2010US20100074878 Probiotic bacterium: lactobacillus fermentum
03/25/2010US20100074872 Compositions and methods for characterizing and restoring gastrointestinal, skin, and nasal microbiota
03/25/2010US20100074870 Probiotic infant products
03/25/2010US20100074867 P1-nonepimerizable ketoamide inhibitors of hcv ns3 protease
03/25/2010US20100074863 Anti-infective pyrrolidine derivatives and analogs
03/25/2010US20100074846 Campylobacter Vaccines and Methods of use
03/25/2010CA2738018A1 Carboxyethylated cyclodextrin polysulfates useful as medicaments
03/25/2010CA2737835A1 Synergistic combinations of a macrocyclic inhibitor of hcv and a nucleoside
03/25/2010CA2737549A1 Compositions and methods for modulating toll-like receptor activity
03/25/2010CA2737524A1 Organic compounds for applications in bacterial infections treatment
03/25/2010CA2737212A1 Dendritic cell modulatory molecule
03/25/2010CA2737055A1 Crystalline forms of a 2-thiazolyl- 4-quinolinyl-oxy derivative, a potent hcv inhibitor
03/25/2010CA2726845A1 Antibodies with altered binding to fcrn and methods of using same
03/25/2010CA2722794A1 Multifunctional linker protein containing an antibody against hemagglutinin, a conserved influenza antigen and an immunostimulating carrier binding domain
03/24/2010EP2166096A2 Moraxella (Branhamella) catarrhalis antigens
1 ... 557 558 559 560 561 562 563 564 565 566 567 568 569 570 571 572 573 574 575 576 577 ... 1798